Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Clinical trials. Found 12 abstracts

Egleston BL, Pedraza O, Wong YN, Griffin CL, Ross EA, Beck JR. Temporal trends and characteristics of clinical trials for which only one racial or ethnic group is eligible. Contemporary Clinical Trials Communications. 2018 Mar;9:135-42.   PMCID: PMC5898501
Godwin JL, Hoffman-Censits J, Plimack E. Recent developments in the treatment of advanced bladder cancer. Urol Oncol. 2018 Mar;36(3):109-14.   PMCID: Review
Wong YN, Manola J, Hudes GR, Roth BJ, Moul JW, Barsevick AM, Scher RM, Volk MJ, Vaughn DJ, Williams SD, Fisch MJ, Cella D, Carducci MA, Wilding G. Phase 2 Study of Weekly Paclitaxel Plus Estramustine in Metastatic Hormone-Refractory Prostate Carcinoma: ECOG-ACRIN Cancer Research Group (E1898) Trial. Clin Genitourin Cancer. 2018 Apr;16(2):e315-e322.   PMCID: PMC5975965
Dotan E. Advancing Treatment Approach to the Older Patient with Cancer Through Clinical Trials Participation. Surg Oncol Clin N Am. 2017 Oct;26(4):719-28.
Ramamurthy C, Chertock Y, Hall MJ. Randomized Controlled Trials in Hereditary Cancer Syndromes. Surgical Oncology Clinics of North America. 2017 Oct;26(4):729-50.   PMCID: REVIEW
Zaorsky NG, Shaikh T, Murphy CT, Hallman MA, Hayes SB, Sobczak ML, Horwitz EM. Comparison of outcomes and toxicities among radiation therapy treatment options for prostate cancer. Cancer Treat Rev. 2016 Jun 17;48:50-60.
Kumar A, Blum KA, Fung HC, Smith MR, Foster PA, Younes A. A phase 1 dose-escalation study of XmAb®2513 in patients with relapsed or refractory Hodgkin lymphoma [Letter]. British Journal of Haematology. 2015 Jan;168(6):902-4.
Fleisher L, Ruggieri DG, Miller SM, Manne S, Albrecht T, Buzaglo J, Collins MA, Katz M, Kinzy TG, Liu T, Manning C, Charap ES, Millard J, Miller DM, Poole D, Raivitch S, Roach N, Ross EA, Meropol NJ. Application of best practice approaches for designing decision support tools: the preparatory education about clinical trials (PRE-ACT) study. Patient education and counseling. 2014 Jul;96(1):63-71.   PMCID: PMC4171039
Simon MA, de la Riva EE, Bergan R, Norbeck C, McKoy JM, Kulesza P, Dong XQ, Schink J, Fleisher L. Improving Diversity in Cancer Research Trials: The Story of the Cancer Disparities Research Network. Journal of Cancer Education. 2014 Jun;29(2):366-74.   PMCID: PMC4029870
Rodrigues G, Bae K, Roach M, Lawton C, Donnelly B, Grignon D, Hanks G, Porter A, Lepor H, Sandler H. IMPACT OF ULTRAHIGH BASELINE PSA LEVELS ON BIOCHEMICAL AND CLINICAL OUTCOMES IN TWO RADIATION THERAPY ONCOLOGY GROUP PROSTATE CLINICAL TRIALS. International Journal of Radiation Oncology Biology Physics. 2011 Jun;80(2):445-52.   PMCID: PMC2952349
Roach M, Bae K, Lawton C, Donnelly BJ, Grignon D, Hanks GE, Porter A, Lepor H, Venketesan V, Sandler H. BASELINE SERUM TESTOSTERONE IN MEN TREATED WITH ANDROGEN DEPRIVATION THERAPY AND RADIOTHERAPY FOR LOCALIZED PROSTATE CANCER. International Journal of Radiation Oncology Biology Physics. 2010 Dec;78(5):1314-22.   PMCID: PMCID: PMC2920356 [Available on 2011/12/1]
Lally BE, Geiger AM, Urbanic JJ, Butler JM, Wentworth S, Perry MC, Wilson LD, Horton JK, Detterbeck FC, Miller AA, Thomas CR, Blackstock AW. Trends in the outcomes for patients with limited stage small cell lung cancer: An analysis of the Surveillance, Epidemiology, and End Results database. Lung Cancer. 2009 Jan;64(2):226-31.   PMCID: NIHMS117386
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Clinical trials

Clinical trials Prostate cancer Neoplasms Chemotherapy Prognostic factors Immunotherapy phase-iii trial Radiation therapy therapy radical prostatectomy Elderly Hodgkin lymphoma Aged Castration resistant Personalized medicine pathology Checkpoint inhibitors level Medical Oncology Clinical Trials as Topic Germline mutations Aging hormonal-therapy Clinical Decision Support Systems Research Subjects Decision Making Platinum ineligible ml Occupational Health Protocols Androgen deprivation therapy underrepresented populations Cancer research SCIENCE Brachytherapy Decision Support Techniques Patient Education as Topic Lynch Hormonal therapy Benchmarking External beam radiation therapy Biobanking methods Eligibility requirements replacement therapy Male Monoclonal antibodies Radiotherapy Scientific Disciplines Education risk Decision aids pathological stage competing Female Quality of life Therapy neoadjuvant PROGRAM Patient Participation Decision support tools predict pathological stage Small cell lung cancer external-beam radiotherapy Patient Care Team Geriatrics Serum testosterone CLINICAL-TRIALS androgen suppression radiotherapy hypogonadal men Minority and MEDICINE Neighborhood characteristics Outcomes cancer patients Cancer PARTICIPATION Oncology Hboc organization & administration Hereditary cancer syndromes SEER Urothelial carcinoma competing risk gleason score Proton therapy Age Factors Older cancer patients Targeted therapy Comparative effectiveness research Patient Selection Metastases Hnpcc Fap Patient-Centered Care 80 and over Aged Bladder cancer Environmental & Public greater-than-20 ng radiation Technology
Last updated on Friday, December 06, 2019